Sign in
Stories
Securities Class Action Alert
Share
AVXL Lawsuit: Deceptive Practices Expose...
Akero Lawsuit: Stock Impact Concerns
Akero Therapeutics Faces Investor Lawsui...
Altimmune Faces Investor Investigation
Overview
API
Kuznicki Law PLLC notifies Amylyx Pharmaceuticals, Inc. shareholders of a securities class action lawsuit for securities bought between Nov 11, 2022, and Nov 8, 2023, with a lead plaintiff application deadline of April 9, 2024. The lawsuit targets false/misleading statements or material information omissions to seek recovery for affected investors.
Ask a question
How might this legal action impact the reputation of Amylyx Pharmaceuticals?
What are the broader implications of this lawsuit on securities trading practices and investor protection?
What measures can companies take to avoid such class action lawsuits in the future?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage